| # | Drug | Count |
|---|---|---|
| 0 | NILOTINIB | 194 |
| 1 | IMATINIB | 146 |
| 2 | DASATINIB | 95 |
| 3 | PONATINIB HYDROCHLORIDE | 44 |
| 4 | IMATINIB MESYLATE | 33 |
| 5 | ASPIRIN | 26 |
| 6 | ASPIRIN 325 MG | 26 |
| 7 | ASPIRIN 81 MG | 26 |
| 8 | FLUDARABINE PHOSPHATE | 24 |
| 9 | BOSUTINIB | 22 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DASATINIB | 95 | 0.0102 |
| 1 | PONATINIB HYDROCHLORIDE | 44 | 0.0084 |
| 2 | NILOTINIB | 194 | 0.0066 |
| 3 | ASCIMINIB | 17 | 0.0049 |
| 4 | BOSUTINIB | 22 | 0.0024 |
| 5 | IMATINIB MESYLATE | 33 | 0.0012 |
| 6 | TREOSULFAN | 3 | 0.0011 |
| 7 | HYDROXYUREA | 19 | 0.0009 |
| 8 | BLINATUMOMAB | 9 | 0.0008 |
| 9 | BUSULFAN | 13 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 62 |
| 1 | Corticosteroid [EPC] | 41 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 35 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 26 |
| 4 | Alkylating Drug [EPC] | 25 |
| 5 | Proton Pump Inhibitor [EPC] | 25 |
| 6 | HMG-CoA Reductase Inhibitor [EPC] | 22 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 21 |
| 8 | Antimetabolite [EPC] | 19 |
| 9 | Xanthine Oxidase Inhibitor [EPC] | 16 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 2 | 0.0008 |
| 1 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |
| 2 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 3 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 1 | 0.0003 |
| 4 | Provitamin D2 Compound [EPC] | 7 | 0.0002 |
| 5 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 6 | Bile Acid [EPC] | 4 | 0.0002 |
| 7 | Stimulant Laxative [EPC] | 2 | 0.0001 |
| 8 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 3 | 0.0001 |
| 9 | Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 15 | 0.0001 |